Joshua F. Wiley

Joshua F. Wiley

Auto-generated profile, based on publicly available information

Joshua F. Wiley

School of Psychological Sciences, Monash University, Victoria, Australia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2018 in Structural Equation Modeling: A Multidisciplinary Journal
Verified
Journal Article
Closed access
MHMichael N. Hallquist
Michael N. Hallquist
JWJoshua F. Wiley
Joshua F. Wiley
MplusAutomation is a package for R that facilitates complex latent variable analyses in Mplus involving comparisons among many models and parameters. More specifically, MplusAutomation provides tools to accomplish 3 objectives: to create and manage Mplus syntax for groups of related models; to automate the estimation of many models; and to extract, aggregate, and compare fit statistics, parameter estimates, and ancillary model outputs. We provide an introduction to the package using applied examples including a large-scale simulation study. By reducing the effort required for large-scale studies, a broad goal of MplusAutomation is to support methodological developments in structural equation modeling using Mplus.

1 August 2016 in Sleep Medicine Reviews
Verified
Journal Article
Open access
BBBei Bei
Bei Bei
JWJoshua F. Wiley
Joshua F. Wiley
JTJohn Trinder
John Trinder
RMRachel Manber
Rachel Manber
Features of an individual's sleep/wake patterns across multiple days are governed by two dimensions, the mean and the intraindividual variability (IIV). The existing literature focuses on the means, while the nature and correlates of sleep/wake IIV are not well understood. A systematic search of records in five major databases from inception to November 2014 identified 53 peer-reviewed empirical publications that examined correlates of sleep/wake IIV in adults. Overall, this literature appeared unsystematic and post hoc, with under-developed theoretical frameworks and inconsistent methodologies. Correlates most consistently associated with greater IIV in one or more aspects of sleep/wake patterns were: younger age, non-White race/ethnicity, living alone, physical health conditions, higher body mass index, weight gain, bipolar and unipolar depression symptomatology, stress, and evening chronotype; symptoms of insomnia and poor sleep were associated with higher sleep/wake IIV, which was reduced following sleep interventions. The effects of experimentally reduced sleep/wake IIV on daytime functioning were inconclusive. In extending current understanding of sleep/wake patterns beyond the mean values, IIV should be incorporated as an additional dimension when sleep is examined across multiple days. Theoretical and methodological shortcomings in the existing literature, and opportunities for future research are discussed.

11 November 2013 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
THThanh N. Huynh
Thanh N. Huynh
EKEric C. Kleerup
Eric C. Kleerup
JWJoshua F. Wiley
Joshua F. Wiley
TSTerrance D. Savitsky
Terrance D. Savitsky
DGDiana Guse
Diana Guse
NWNeil S. Wenger
Neil S. Wenger
Advances in medicine enable critical care specialists to save lives as well as prolong dying. An admission to the intensive care unit (ICU) should be considered a therapeutic trial—aggressive critical care should transition to palliative care once it is clear that the treatment will not achieve an acceptable health state for the patient.1,2 However, intensive care interventions often sustain life under circumstances that will not achieve an outcome that patients can meaningfully appreciate. Such treatments are often perceived to be “futile” by health care providers.3 A survey of ICU physicians in Canada found that as many as 87% believed that futile treatment had been provided in their ICU in the past year.3 In a single-day cross-sectional study performed in Europe, 27% of ICU clinicians believed that they provided “inappropriate” care to at least 1 patient, and most of the inappropriate care was deemed such because it was excessive.4

12 December 2013 in Depression and Anxiety
Verified
Journal Article
Closed access
PDF file
HDHalina J. Dour
Halina J. Dour
JWJoshua F. Wiley
Joshua F. Wiley
PRPeter Roy-Byrne
Peter Roy-Byrne
MSMurray B. Stein
Murray B. Stein
GSGreer Sullivan
Greer Sullivan
MCMichelle G. Craske
Michelle G. Craske
Background The current study tested whether perceived social support serves as a mediator of anxiety and depressive symptom change following evidence‐based anxiety treatment in the primary care setting. Gender, age, and race were tested as moderators. Methods Data were obtained from 1004 adult patients (age M = 43, SD = 13; 71% female; 56% White, 20% Hispanic, 12% Black) who participated in a randomized effectiveness trial (coordinated anxiety learning and management [CALM] study) comparing evidence‐based intervention (cognitive‐behavioral therapy and/or psychopharmacology) to usual care in the primary care setting. Patients were assessed with a battery of questionnaires at baseline, as well as at 6, 12, and 18 months following baseline. Measures utilized in the mediation analyses included the Abbreviated Medical Outcomes (MOS) Social Support Survey, the Brief Symptom Index (BSI)–Somatic and Anxiety subscales, and the Patient Health Questionnaire (PHQ‐9). Results There was a mediating effect over time of perceived social support on symptom change following treatment, with stronger effects for 18‐month depression than anxiety. None of the mediating pathways were moderated by gender, age, or race. Conclusions Perceived social support may be central to anxiety and depressive symptom changes over time with evidence‐based intervention in the primary care setting. These findings possibly have important implications for development of anxiety interventions.

14 October 2019 in SLEEP
Verified
Journal Article
Closed access
PDF file
YYYang Yap
Yang Yap
DSDanica C Slavish
Danica C Slavish
DTDaniel J Taylor
Daniel J Taylor
BBBei Bei
Bei Bei
JWJoshua F Wiley
Joshua F Wiley
Stress is associated with poor and short sleep, but the temporal order of these variables remains unclear. This study examined the temporal and bi-directional associations between stress and sleep, and explored the moderating role of baseline sleep complaints, using daily, intensive longitudinal designs. Participants were 326 young adults (Mage=23.24±5.46), providing >2,500 nights of sleep altogether. Prospective total sleep time (TST), sleep onset latency (SOL), wake after sleep onset (WASO), and sleep efficiency (SE) were measured using actigraphy and sleep diaries. Perceived stress was reported three times daily between: 11:00–15:00, 15:30–19:30, and 20:00–02:00. Sleep complaints were measured at baseline using the PROMIS sleep disturbance scale. Within and between-person sleep and stress variables were tested using cross-lagged multilevel models. Controlling for covariates and lagged outcomes, within-person effects showed that higher evening stress predicted shorter actigraphic and self-reported TST (both p<.01). Conversely, shorter actigraphic and self-reported TST predicted higher next-day stress (both p<.001). Longer self-reported SOL and WASO (both p<.001), as well as lower actigraphic (p<.01) and self-reported SE (p<.001) predicted higher next-day stress. Between-person effects emerged only for self-reported TST predicting stress (p<.01). No significant results were found for the moderating role of baseline sleep complaints. Results demonstrated bi-directional relations between stress and sleep quantity, and a consistent direction of worse sleep quantity and continuity predicting higher next-day stress. Results highlighted within-individual daily variation as being more important than between-individual differences when examining sleep and daytime functioning associations.

5 August 2013 in Journal of Clinical Child & Adolescent Psychology
Verified
Journal Article
Closed access
ALAudra K. Langley
Audra K. Langley
AFAvital Falk
Avital Falk
TPTara Peris
Tara Peris
JWJoshua F. Wiley
Joshua F. Wiley
PKPhilip C. Kendall
Philip C. Kendall
JPJohn Piacentini
John Piacentini
The purpose of the current investigation was to examine the factor structure, reliability, and construct validity of both the Child and Parent version of the Child Anxiety Impact Scale (CAIS) using data obtained from the Child/Adolescent Anxiety Multimodal Study (Walkup et al., 2008 Walkup , J. , Albano , A. M. , Piacentini , J. C. , Birmaher , B. , Compton , S. , & Sherrill , J. ( 2008 ). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety . The New England Journal of Medicine , 359 , 2753 – 2766 . [Crossref], [PubMed], [Web of Science ®] , [Google Scholar] ). The CAIS child and parent versions measure anxiety-related functional impairment in school, social, and family domains. Participants were 488 children ages 7 to 17 (M age = 10.7, SD = 2.8 years) enrolled as part of the CAMS study across 6 sites and their primary parent or caregiver. Families participated in a structured diagnostic interview and then completed the CAIS along with other measures. Confirmatory factor analysis revealed that the a priori three-factor structure (school, social, and home/family) for the CAIS parent- and CAIS child-report was a reasonable fit, with a comparative fit index of .88 and root mean square error of approximation of .05. Internal consistency was very good for total score and subscales of both versions of the scale (Cronbach's α = .70–.90). The CAIS total scores demonstrated good construct validity, showing predicted significant correlations with the Child Behavior Checklist (CBCL) Internalizing Scale, the Multidimensional Anxiety Scale for Children (MASC) and Screen for Child Anxiety Related Emotional Disorders (SCARED) Total Scores, the Pediatric Anxiety Rating Scale, and the Children's Global Assessment Scale. In addition, CAIS Social and School subscales were significantly related to similar subscales on the CBCL, SCARED, and MASC. The results provide support that the CAIS is a reliable and valid measure for the assessment of the impact of anxiety on child and adolescent functioning.